JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB68236

Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

Be the first to review this product! Submit a review

|

(21 Publications)

Rabbit Recombinant Monoclonal CD3 zeta phospho Y83 antibody. Suitable for IP, Flow Cyt (Intra), Dot, WB, ICC/IF and reacts with Human, Synthetic peptide samples. Cited in 21 publications.

View Alternative Names

CD247, CD3Z, T3Z, TCRZ, T-cell surface glycoprotein CD3 zeta chain, T-cell receptor T3 zeta chain

6 Images
Flow Cytometry (Intracellular) - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

Flow Cytometry analysis of Jurkat (human acute T cell leukemia) treated (Red)/untreated (Green) with 1mM pervanadate for 4 hours with purified ab68236 at 1/250 dilution. The secondary antibody was Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution. A Rabbit monoclonal IgG (Black) was used as the isotype control and cells without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.

Immunocytochemistry/ Immunofluorescence - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

Immunocytochemistry/Immunofluorescence analysis of Jurkat cells (untreated, Per treated and Per+LP treated) labelling CD3 zeta (phospho Y83) with ab68236 (left) and CD3 zeta with ab40804 (right) both at a dilution of 1/200. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

The image shows increased cytoplamic staining after Pervanadate (1 mM, 30 min) treatment on Jurkat cells. The LP treatment decreased the cytoplasmic staining caused by Pervanadate.

ab40804 was used as a Pan control for ab68236. The results showed cytoplamic staining on untreated, pervanadate (1 mM, 30 min) treated and Per+LP treated Jurkat cells.

Immunoprecipitation - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • IP

Lab

Immunoprecipitation - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

CD3 zeta was immunoprecipitated from 0.35 mg Jurkat (Human T cell leukemia T lymphocyte) treated with pervandate (50mM 5min) whole cell lysate 10 μg with ab68236 at 1/30 dilution (2μg) . VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : Jurkat (Human T cell leukemia T lymphocyte) treated with pervandate (50mM 5min) whole cell lysate 10 μg

Lane 2 : ab68236 IP in Jurkat treated with pervandate (50mM 5min) whole cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab68236 in Jurkat treated with pervandate (50mM 5min) whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236)

Predicted band size: 19 kDa

Observed band size: 18-22 kDa

false

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • WB

Lab

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

Blocking buffer 5% NFDM/TBST

Diluting buffer 5% NFDM/TBST

All lanes:

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236) at 1/2000 dilution

Lane 1:

Untreated Jurkat cells whole cell lysates at 10 µg

Lane 2:

Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates at 10 µg

Lane 3:

Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates, then the membrane was incubated with Alkaline phosphatase at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 19 kDa

Observed band size: 18 kDa

false

Exposure time: 3min

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • WB

Unknown

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

All lanes:

Western blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (ab68236) at 1/10000 dilution

Lane 1:

Jurkat cell lysate, untreated. at 10 µg

Lane 2:

Jurkat cell lysate, treated with pervanadate at 10 µg

Secondary

All lanes:

HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution

Predicted band size: 19 kDa

Observed band size: 18-22 kDa

false

Dot Blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)
  • Dot

Unknown

Dot Blot - Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] (AB68236)

Dot blot analysis of CD3 zeta (pY83) phospho peptide (lane 1) and CD3 zeta non-phospho peptide (lane 2) labelling CD3 zeta (phospho Y83) with ab68236 at a dilution of 1/1000. A peroxidase-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/2500).

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

  • 519 FITC

    FITC Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

  • Carrier free

    Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y] - BSA and Azide free

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-CD3 zeta (phospho Y83) antibody [EP776(2)Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP776(2)Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IP, Dot, Flow Cyt (Intra), WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Synthetic peptide": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways (PubMed : 1384049, PubMed : 1385158, PubMed : 2470098, PubMed : 7509083). CD3Z ITAMs phosphorylation creates multiple docking sites for the protein kinase ZAP70 leading to ZAP70 phosphorylation and its conversion into a catalytically active enzyme (PubMed : 7509083). Plays an important role in intrathymic T-cell differentiation. Additionally, participates in the activity-dependent synapse formation of retinal ganglion cells (RGCs) in both the retina and dorsal lateral geniculate nucleus (dLGN) (By similarity).
See full target information CD247 phospho Y83

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1571590 PubMed40642095

2025

The OT-II model reveals dual and immunomodulatory properties of CD6 in T cell activation.

Applications

Unspecified application

Species

Unspecified reactive species

Alejandra Leyton-Pereira,Irene Fernández-Delgado,María José Rodríguez-Lagunas,Cristina Català,Sergi Casadó-Llombart,Noa Beatriz Martin-Cofreces,Eugenio Bustos-Morán,Natalia Díaz-Garrido,Marta Consuegra-Fernández,Ana Cristina Calpena,Fernando Aranda,María Velasco-de Andrés,Laura Baldomà,Francisco Sánchez-Madrid,Francisco Lozano

iScience 28:112266 PubMed40241752

2025

CRISPR/Cas9-mediated SHP-1-knockout T cells combined with simvastatin enhances anti-tumor activity in humanized-PDX HCC model.

Applications

Unspecified application

Species

Unspecified reactive species

Huaping Liu,Wu Ge,Xiaoping Yu,Jianwei Luo,Juan Zhang,Min Yang,Lu Cao,Yangnan Zhang,Ruike Wang,Cejun Yang,Pei Li,Mengyu Tian,XiaoPei Peng,Lei Peng,Di Wu,Muqi Liu,Qi Liang,Shengwang Zhang,Wei Li,Pengfei Rong,Hailan Li,Xiaoqian Ma,Wei Wang

Cell reports 43:114761 PubMed39276348

2024

Ligand-induced segregation from large cell-surface phosphatases is a critical step in γδ TCR triggering.

Applications

Unspecified application

Species

Unspecified reactive species

Fenglei Li,Sobhan Roy,Jacob Niculcea,Keith Gould,Erin J Adams,P Anton van der Merwe,Kaushik Choudhuri

Molecular cancer 22:200 PubMed38066564

2023

Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.

Applications

Unspecified application

Species

Unspecified reactive species

Yunlin Zhang,Ruchi P Patel,Ki Hyun Kim,Hyungwoo Cho,Jae-Cheol Jo,Seong Hyun Jeong,Sung Yong Oh,Yoon Seok Choi,Sung Hyun Kim,Ji Hyun Lee,Mathew Angelos,Puneeth Guruprasad,Ivan Cohen,Ositadimma Ugwuanyi,Yong Gu Lee,Raymone Pajarillo,Jong Hyun Cho,Alberto Carturan,Luca Paruzzo,Guido Ghilardi,Michael Wang,Soohwan Kim,Sung-Min Kim,Hyun-Jong Lee,Ji-Ho Park,Leiguang Cui,Tae Bum Lee,In-Sik Hwang,Young-Ha Lee,Yong-Jun Lee,Patrizia Porazzi,Dongfang Liu,Yoon Lee,Jong-Hoon Kim,Jong-Seo Lee,Dok Hyun Yoon,Junho Chung,Marco Ruella

eLife 12: PubMed37796108

2023

Allosteric inhibition of the T cell receptor by a designed membrane ligand.

Applications

Unspecified application

Species

Unspecified reactive species

Yujie Ye,Shumpei Morita,Justin J Chang,Patrick M Buckley,Kiera B Wilhelm,Daniel DiMaio,Jay T Groves,Francisco N Barrera

Communications biology 6:911 PubMed37670137

2023

INPP5E regulates CD3ζ enrichment at the immune synapse by phosphoinositide distribution control.

Applications

Unspecified application

Species

Unspecified reactive species

Tzu-Yuan Chiu,Chien-Hui Lo,Yi-Hsuan Lin,Yun-Di Lai,Shan-Shan Lin,Ya-Tian Fang,Wei-Syun Huang,Shen-Yan Huang,Pei-Yuan Tsai,Fu-Hua Yang,Weng Man Chong,Yi-Chieh Wu,Hsing-Chen Tsai,Ya-Wen Liu,Chia-Lin Hsu,Jung-Chi Liao,Won-Jing Wang

International journal of molecular sciences 22: PubMed33572206

2021

A Role for Human Renal Tubular Epithelial Cells in Direct Allo-Recognition by CD4+ T-Cells and the Effect of Ischemia-Reperfusion.

Applications

Unspecified application

Species

Unspecified reactive species

Theodoros Eleftheriadis,Georgios Pissas,Marta Crespo,Evdokia Nikolaou,Vassilios Liakopoulos,Ioannis Stefanidis

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:8959-8974 PubMed32469452

2020

PTPN22 interacts with EB1 to regulate T-cell receptor signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaonan Zhang,Yang Yu,Bin Bai,Tao Wang,Jiahui Zhao,Na Zhang,Yanjiao Zhao,Xipeng Wang,Bing Wang

Cancer cell 37:216-225.e6 PubMed32004441

2020

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Chuang Sun,Peishun Shou,Hongwei Du,Koichi Hirabayashi,Yuhui Chen,Laura E Herring,Sarah Ahn,Yang Xu,Kyogo Suzuki,Guangming Li,Ourania Tsahouridis,Lishan Su,Barbara Savoldo,Gianpietro Dotti

Cell reports 29:3506-3521.e6 PubMed31825832

2019

T Cell Activation through Isolated Tight Contacts.

Applications

Unspecified application

Species

Unspecified reactive species

Yair Razvag,Yair Neve-Oz,Julia Sajman,Oren Yakovian,Meital Reches,Eilon Sherman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com